September 4, 2020
Gillette Helps With New Treatments and Choices for SMA Patients
The U.S. Food Drug Administration’s (FDA’s) recent approval of a new oral medication to help treat spinal muscular atrophy (SMA) is being hailed as a “game changer” by Gillette Children's neurologist, Randal Richardson, MD, MMS. “The main message I want to get out to people who have SMA and their families is—many of you now have options and the power to make a choice for yourself,” Richardson says.